Cargando…
Antithrombotic prophylaxis in children and adolescent patients with SARS-CoV-2 (COVID-19) infection: A practical guidance for clinicians
Severe coronavirus disease 2019 (COVID-19) is often associated with features of the hypercoagulable state which can manifest as venous thromboembolism (VTE) and/or microthrombosis. Given the high risk of VTE in critically ill COVID-19 patients, appropriate VTE prophylaxis seems to be an important pa...
Autores principales: | Karimi, Mehran, Bozorgi, Haleh, Zarei, Tahereh, Bordbar, Mohammadreza, Amanati, Ali, Safaei, Arash, De Sanctis, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927562/ https://www.ncbi.nlm.nih.gov/pubmed/33525215 http://dx.doi.org/10.23750/abm.v91i4.10720 |
Ejemplares similares
-
Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β -Thalassemia Patients and effects of Associated Comorbidities: An Iranian Nationwide study
por: Karimi, Mehran, et al.
Publicado: (2020) -
Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the “high clinical risk” category?
por: Karimi, Mehran, et al.
Publicado: (2020) -
Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience
por: Karimi, Mehran, et al.
Publicado: (2021) -
Antithrombotic Prophylaxis in the Middle East
por: Arnaout, Samir, et al.
Publicado: (2011) -
Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study
por: Mottaghipisheh, Hadi, et al.
Publicado: (2021)